ID

31073

Descripción

GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00576758

Link

https://clinicaltrials.gov/show/NCT00576758

Palabras clave

Versiones (1)
  1. 17/7/18 17/7/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

17 de julio de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-Hodgkin's Lymphoma NCT00576758

Inglés

Eligibility Non-Hodgkin's Lymphoma NCT00576758

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age
Descripción

Adult | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
relapsed cd20+ indolent b-cell non-hodgkin's lymphoma
Descripción

B-cell lymphoma recurrent CD20 positive indolent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0855089
UMLS CUI [1,2]
C3888518
UMLS CUI [1,3]
C0234227
documented history of response of >/= 6 months duration from last rituximab-containing regimen
Descripción

Disease Response Due to Rituximab therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1704632
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C4047978
clinical indication for treatment as determined by the investigator
Descripción

Indication Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0087111
eastern cooperative oncology group (ecog) performance status 0-2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior use of any investigational monoclonal antibody within 6 months of study start
Descripción

Monoclonal Antibodies Investigational

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003250
UMLS CUI [1,2]
C1517586
prior use of any anti-cancer vaccine
Descripción

Cancer Vaccines

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0376659
prior use of rituximab within 8 weeks of study entry
Descripción

Rituximab Use of Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0393022
UMLS CUI [1,2]
C1524063
UMLS CUI [1,3]
C0205156
radioimmunotherapy within 3 months prior to study entry
Descripción

Radioimmunotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085101
central nervous system (cns) lymphoma or evidence of transformation to high-grade or diffuse large b-cell lymphoma
Descripción

Central nervous system lymphoma | Transformation High grade B-cell lymphoma | Transformation Diffuse Large B-Cell Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0742472
UMLS CUI [2,1]
C0040682
UMLS CUI [2,2]
C0456863
UMLS CUI [3,1]
C0040682
UMLS CUI [3,2]
C0079744
Volver a la parte superior de la página

Similar models

Eligibility Non-Hodgkin's Lymphoma NCT00576758

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >=18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
B-cell lymphoma recurrent CD20 positive indolent
Item
relapsed cd20+ indolent b-cell non-hodgkin's lymphoma
boolean
C0855089 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C0234227 (UMLS CUI [1,3])
Disease Response Due to Rituximab therapy
Item
documented history of response of >/= 6 months duration from last rituximab-containing regimen
boolean
C1704632 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C4047978 (UMLS CUI [1,3])
Indication Therapeutic procedure
Item
clinical indication for treatment as determined by the investigator
boolean
C3146298 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Monoclonal Antibodies Investigational
Item
prior use of any investigational monoclonal antibody within 6 months of study start
boolean
C0003250 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
Cancer Vaccines
Item
prior use of any anti-cancer vaccine
boolean
C0376659 (UMLS CUI [1])
Rituximab Use of Previous
Item
prior use of rituximab within 8 weeks of study entry
boolean
C0393022 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
Radioimmunotherapy
Item
radioimmunotherapy within 3 months prior to study entry
boolean
C0085101 (UMLS CUI [1])
Central nervous system lymphoma | Transformation High grade B-cell lymphoma | Transformation Diffuse Large B-Cell Lymphoma
Item
central nervous system (cns) lymphoma or evidence of transformation to high-grade or diffuse large b-cell lymphoma
boolean
C0742472 (UMLS CUI [1])
C0040682 (UMLS CUI [2,1])
C0456863 (UMLS CUI [2,2])
C0040682 (UMLS CUI [3,1])
C0079744 (UMLS CUI [3,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial